Another evidence that linked NF-κB activation in the absence of RIPK3 with CRC progression was provided by our results showing dramatic increase in the expression of cytokines (TNFα and IL-1β) and chemokines (CCL2, CXCL1 and CXCL2). This evidence concerns the gene CXCL2 and colorectal carcinoma.